Literature DB >> 10066796

An ankyrin-like protein with transmembrane domains is specifically lost after oncogenic transformation of human fibroblasts.

D Jaquemar1, T Schenker, B Trueb.   

Abstract

We have identified a novel transformation-sensitive mRNA, which is present in cultured fibroblasts but is lacking in SV40 transformed cells as well as in many mesenchymal tumor cell lines. The corresponding gene is located on human chromosome 8 in band 8q13. The open reading frame of the mRNA encodes a protein of 1119 amino acids forming two distinct domains. The N-terminal domain consists of 18 repeats that are related to the cytoskeletal protein ankyrin. The C-terminal domain contains six putative transmembrane segments that resemble many ion channels. This overall structure is reminiscent of TRP-like proteins that function as store-operated calcium channels. The novel protein with an Mr of 130 kDa is expressed at a very low level in human fibroblasts and at a moderate level in liposarcoma cells. Overexpression in eukaryotic cells appears to interfere with normal growth, suggesting that it might play a direct or indirect role in signal transduction and growth control.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10066796     DOI: 10.1074/jbc.274.11.7325

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  104 in total

Review 1.  Structure of thermally activated TRP channels.

Authors:  Matthew R Cohen; Vera Y Moiseenkova-Bell
Journal:  Curr Top Membr       Date:  2014       Impact factor: 3.049

Review 2.  The functions of TRPA1 and TRPV1: moving away from sensory nerves.

Authors:  E S Fernandes; M A Fernandes; J E Keeble
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

3.  The pore properties of human nociceptor channel TRPA1 evaluated in single channel recordings.

Authors:  Y V Bobkov; E A Corey; B W Ache
Journal:  Biochim Biophys Acta       Date:  2010-12-29

Review 4.  TRPing on the pore phenomenon: what do we know about transient receptor potential ion channel-related pore dilation up to now?

Authors:  L G B Ferreira; R X Faria
Journal:  J Bioenerg Biomembr       Date:  2016-01-04       Impact factor: 2.945

5.  Sensitization of TRPA1 by PAR2 contributes to the sensation of inflammatory pain.

Authors:  Yi Dai; Shenglan Wang; Makoto Tominaga; Satoshi Yamamoto; Tetsuo Fukuoka; Tomohiro Higashi; Kimiko Kobayashi; Koichi Obata; Hiroki Yamanaka; Koichi Noguchi
Journal:  J Clin Invest       Date:  2007-07       Impact factor: 14.808

6.  TRPA1 channels: expression in non-neuronal murine lung tissues and dispensability for hyperoxia-induced alveolar epithelial hyperplasia.

Authors:  Martina Kannler; Robin Lüling; Ali Önder Yildirim; Thomas Gudermann; Dirk Steinritz; Alexander Dietrich
Journal:  Pflugers Arch       Date:  2018-05-12       Impact factor: 3.657

Review 7.  Breathtaking TRP channels: TRPA1 and TRPV1 in airway chemosensation and reflex control.

Authors:  Bret F Bessac; Sven-Eric Jordt
Journal:  Physiology (Bethesda)       Date:  2008-12

8.  The peptide Phα1β, from spider venom, acts as a TRPA1 channel antagonist with antinociceptive effects in mice.

Authors:  Raquel Tonello; Camilla Fusi; Serena Materazzi; Ilaria M Marone; Francesco De Logu; Silvia Benemei; Muryel C Gonçalves; Elisabetta Coppi; Celio J Castro-Junior; Marcus Vinicius Gomez; Pierangelo Geppetti; Juliano Ferreira; Romina Nassini
Journal:  Br J Pharmacol       Date:  2016-11-28       Impact factor: 8.739

9.  The TRPA1 channel mediates the analgesic action of dipyrone and pyrazolone derivatives.

Authors:  Romina Nassini; Camilla Fusi; Serena Materazzi; Elisabetta Coppi; Tiziano Tuccinardi; Ilaria M Marone; Francesco De Logu; Delia Preti; Raquel Tonello; Alberto Chiarugi; Riccardo Patacchini; Pierangelo Geppetti; Silvia Benemei
Journal:  Br J Pharmacol       Date:  2015-04-24       Impact factor: 8.739

Review 10.  TRP channels: potential drug target for neuropathic pain.

Authors:  Lovish Marwaha; Yashika Bansal; Raghunath Singh; Priyanka Saroj; Ranjana Bhandari; Anurag Kuhad
Journal:  Inflammopharmacology       Date:  2016-10-18       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.